Ligand validation:4WLZ

UDP: URIDINE-5'-DIPHOSPHATE

UDP is a Ligand Of Interest in 4WLZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WLZ_UDP_A_402	45%	33%	0.198	0.932	1.09	1.54	2	5	0	0	100%	1
4WLZ_UDP_B_402	5%	32%	0.346	0.759	1.12	1.55	2	5	0	0	100%	1
4WMB_UDP_A_402	92%	33%	0.091	0.982	1.05	1.57	1	6	0	0	100%	1
4WN2_UDP_A_402	84%	24%	0.088	0.949	1.14	1.97	3	10	0	0	100%	0.6
4WMK_UDP_A_402	79%	29%	0.101	0.945	1.15	1.67	3	5	1	0	100%	1
4WMI_UDP_A_402	76%	28%	0.104	0.939	1.08	1.81	3	8	2	0	100%	1
8X3Q_UDP_C_401	100%	3%	0.015	0.998	3.32	2.69	13	13	0	0	100%	1
8X3U_UDP_B_401	100%	3%	0.012	0.999	3.31	2.68	13	13	2	0	100%	1
8VH8_UDP_D_702	100%	67%	0.032	0.995	0.59	0.69	-	-	0	0	100%	1
2IV7_UDP_A_1372	100%	40%	0.035	0.984	0.85	1.49	-	4	0	0	100%	1
4PHR_UDP_A_301	100%	42%	0.042	0.989	0.84	1.41	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.